Effectiveness of Transcutaneous Electrical Nerve Stimulation and Interferential Current in Chronic Neck Pain
20 de agosto de 2026 actualizado por: Busra Sirin, Beylikduzu State Hospital
Comparison of the Therapeutic Effectiveness of Transcutaneous Electrical Nerve Stimulation and Interferential Current in Patients With Chronic Neck Pain: A Prospective, Randomized, Double-Blind Study
The aim of this study was to determine and compare the efficacy of transcutaneous electrical nerve stimulation (TENS), interferential current (IFC), and sham therapy in patients with chronic neck pain.
A total of 57 patients diagnosed with chronic mechanical neck pain were included in the study. Patients were randomized into three groups. Each group received 10 sessions of physiotherapy over a two-week period: one group received conventional TENS, one group received IFC, and one group received sham therapy. Pain was assessed using the Visual Analog Scale (VAS), disability and functionality using the Copenhagen Neck Disability Index, quality of life using the SF-36, depression using the Beck Depression Inventory (BDI), and pain characteristics using the SF-McGill Pain Questionnaire.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Actual)
57
Fase
- No aplica
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Sí
Descripción
The inclusion criteria:
- having neck pain for more than six months,
- being between 18 and 60 years of age,
- having sufficient cognitive capacity to complete the study questionnaires,
- being functionally able to participate in an outpatient physical therapy program
- voluntarily agreeing to participate in the study.
The exclusion criteria:
- the presence of motor deficits due to neurological involvement;
- neurological conditions causing dizziness or balance loss;
- congenital pathology of the cervical spine;
- uncontrolled diabetes mellitus or hypertension; any contraindication to electrotherapy (such as pregnancy, severe arrhythmia, pacemaker, active infection, or skin lesions);
- having received physical therapy or injection treatment for the neck region within the past year;
- the presence of any connective tissue or rheumatologic disease (such as seronegative spondyloarthropathies or rheumatoid arthritis);
- the presence of a mass lesion in the cervical spine or neck region;
- a history of cervical spine fracture; and
- the presence of psychiatric or cognitive disorders.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: patients who received TENS for chronic neck pain
Transcutaneous electrical nerve stimulation (TENS) was applied to the cervical region using four electrodes.
Treatment was administered using a FİZYOMED FİZYOTENS-4000 device in conventional mode with a stimulation frequency of 40 Hz and a pulse duration of 100 μs.
Each session lasted 20 minutes.
Treatment was administered for 10 sessions over 2 weeks.
Participants also received a home exercise program and education on protective techniques.
|
Transcutaneous electrical nerve stimulation (TENS) was applied to the cervical region using four electrodes.
Treatment was administered using a FİZYOMED FİZYOTENS-4000 device in conventional mode with a stimulation frequency of 40 Hz and a pulse duration of 100 μs.
Each session lasted 20 minutes.
Treatment was administered for 10 sessions over 2 weeks.
Participants also received a home exercise program and education on protective techniques.
|
|
Experimental: patients who received IFC for chronic neck pain
Interferential current (IFC) therapy was applied to the cervical region using four electrodes and an ET 3000 combined electrotherapy device.
Treatment was administered with a carrier frequency of 4000 Hz, a stimulation frequency of 40 Hz, and an amplitude-modulated frequency (AMF) of 40 Hz using a 1/1 rectangular spectrum.
Each session lasted 20 minutes.
Treatment was administered for 10 sessions over 2 weeks.
Participants also received a home exercise program and education on protective techniques.
|
Interferential current (IFC) therapy was applied to the cervical region using four electrodes and an ET 3000 combined electrotherapy device.
Treatment was administered with a carrier frequency of 4000 Hz, a stimulation frequency of 40 Hz, and an amplitude-modulated frequency (AMF) of 40 Hz using a 1/1 rectangular spectrum.
Each session lasted 20 minutes.
Treatment was administered for 10 sessions over 2 weeks.
Participants also received a home exercise program and education on protective techniques.
|
|
Comparador falso: Control
Sham electrotherapy was applied to the cervical region using four electrodes.
The electrotherapy device was turned on, but no electrical current was delivered.
Each sham treatment session lasted 20 minutes.
Treatment was administered for 10 sessions over 2 weeks.
Participants also received a home exercise program and education on protective techniques.
|
Sham electrotherapy was applied to the cervical region using four electrodes.
The electrotherapy device was turned on, but no electrical current was delivered.
Each sham treatment session lasted 20 minutes.
Treatment was administered for 10 sessions over 2 weeks.
Participants also received a home exercise program and education on protective techniques.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Short-Form McGill Pain Questionnaire (SF-MPQ):
Periodo de tiempo: Baseline, 3th weeks
|
The SF-MPQ, developed by Melzack in 1987 and validated in Turkish by Yakut et al., is widely used to assess pain.
It evaluates sensory, affective, and total pain dimensions, along with VAS and Present Pain Intensity (PPI).
The questionnaire consists of 15 descriptors (11 sensory and 4 affective), each scored from 0 (none) to 3 (severe), yielding sensory, affective, and total pain scores.
PPI is assessed using a 6-point Likert scale ranging from 0 (no pain) to 5 (unbearable pain)
|
Baseline, 3th weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Beck Depression Inventory (BDI):
Periodo de tiempo: Baseline, 3th weeks
|
The BDI was developed by Beck et al., and its Turkish validity and reliability have been established.
The total score ranges from 0 to 63, with 0-21 indicating mild, 21-42 moderate, and 42-63 severe depression.
|
Baseline, 3th weeks
|
|
Copenhagen Neck Functional Disability Index (CNFDI): Copenhagen Neck Functional Disability Index (CNFDI):
Periodo de tiempo: Baseline, 3th weeks
|
The CNFDI was developed by Jordan et al. in 1998, and its Turkish version was validated by Yapalı et al.
It consists of 15 items assessing pain intensity and its impact on daily activities, social interaction, and functional disability.
Total scores range from 0 to 30.
|
Baseline, 3th weeks
|
|
Short Form-36 (SF-36)
Periodo de tiempo: Baseline, 3th weeks
|
The Turkish version of SF-36 was validated by Koçyiğit et al.
It consists of 36 items and 8 subscales assessing physical and mental health: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health.
|
Baseline, 3th weeks
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
1 de enero de 2015
Finalización primaria (Actual)
1 de mayo de 2015
Finalización del estudio (Actual)
1 de mayo de 2015
Fechas de registro del estudio
Enviado por primera vez
15 de agosto de 2026
Primero enviado que cumplió con los criterios de control de calidad
20 de agosto de 2026
Publicado por primera vez (Actual)
21 de agosto de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
21 de agosto de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
20 de agosto de 2026
Última verificación
1 de agosto de 2026
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- bdh2000
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .